Results 121 to 130 of about 335 (142)

Characteristics of the Fatty Acid Composition in Elderly Patients with Occupational Pathology from Organophosphate Exposure. [PDF]

Diagnostics (Basel)
Goncharov NV, Savelieva EI, Koneva TA, Gustyleva LK, Vasilieva IA, Belyakov MV, Voitenko NG, Belinskaia DA, Korf EA, Jenkins RO.   +9 more
europepmc   +1 more source

L-Carnitine and Mildronate Demonstrate Divergent Protective Effects on Mitochondrial DNA Quality Control and Inflammation Following Traumatic Brain Injury. [PDF]

Int J Mol Sci
Gureev AP, Nesterova VV, Babenkova PI, Ivanov ME, Plotnikov EY, Silachev DN.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Meldonium in Treatment of Patients With Myocardial Infarction

Kardiologiia, 2014
Therapy with meldonium belongs to "metabolic direction" which is developing in cardiovascular medicine. Its purpose is restoration of impaired cellular metabolism.
G I, Nechaeva, D A, Potashov, E N, Zheltikova   +2 more
openaire   +2 more sources

Testing Meldonium: Assessing Soviet pragmatic alternatives to the randomized controlled trial

Clinical Trials, 2021
Background/aims Current research largely tends to ignore the drug-testing model that was developed in the “Second World” as an explicit alternative to the randomized controlled trial. This system can be described as “socialist pharmapolitics,” accounting for the specific features of state socialism that influenced the development and testing of ...
Anastasiya Chirkova, Alexander Petrenko, Pavel Vasilyev   +2 more
openaire   +2 more sources

Analytical methods for meldonium determination in urine samples

Analytical Letters, 2020
Here is reported a rapid analytical method for meldonium and other beta blockers (metoprolol, amlodipine, bisoprolol, nebivolol, betaxolol, and carvediol) in urine samples using Fourier transform i...
L. D. Rusu, I. Bratu, C. Măruțoiu, Z. Moldovan, M. Rada   +4 more
openaire   +1 more source

Sixty seconds on . . . meldonium

BMJ, 2016
Yes, definitely a double fault for the Russian tennis star. Meldonium (also known as mildronate) is a drug made in Latvia used for treating heart failure, angina, and myocardial infarction. It isn’t licensed in the United States or Europe. We don’t know, but it seems unlikely. She has said that she had magnesium …
openaire   +1 more source

Urinary excretion studies of meldonium after multidose parenteral application

Journal of Pharmaceutical and Biomedical Analysis, 2018
Meldonium is a drug exhibiting cardioprotective and anti-ischemic effects. Due to its potential performance-enhancing benefit in sports, meldonium was added to the World Anti-Doping Agency list of prohibited substances in 2016. Since then, a high number of adverse analytical findings reported on meldonium has questioned meldonium`s detection time in ...
Guro Forsdahl, Biljana Jančić-Stojanović, Marija Anđelković, Nenad Dikić, Tomas Geisendorfer, Veronika Jeitler, Günter Gmeiner   +6 more
openaire   +4 more sources

Chronic cerebrovascular diseases and neuroprotection: the clinical efficacy of meldonium (Mildronat)

Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2020
To evaluate the efficacy of meldonium (mildronat) in patients with chronic cerebral vascular disease (CVD).An open comparative study of the clinical efficacy of meldonium (mildronat) in patients with chronic CVD caused by arterial hypertension and atherosclerosis was conducted.
M M, Tanashyan, M Yu, Maksimova, A A, Shabalina, P A, Fedin, R B, Medvedev, T A, Bolotova   +5 more
openaire   +2 more sources

Optoelectronical method for identification of meldonium in urine samples

Advanced Topics in Optoelectronics, Microelectronics, and Nanotechnologies IX, 2018
Meldonium is an anti-ischemia drug developed in 1970 by Ivars Kalvins at the USSR Latvia Institute of organic synthesis. Meldonium is reportedly capable of providing clinical benefit for those suffering from heart conditions, such as low blood flow to the heart and angina, as well as neurodegenerative disorders and bronchopulmonary diseases. It appears
Georgeta Marcela Bican, Mihai Ionica, Mihai Radu, Bogdan Berghes, Jeni -Carla Colev   +4 more
openaire   +1 more source

Efficiency of Meldonium in the Complex Therapy of Acute Coronary Syndrome

Kardiologiia, 2014
We examined 140 patients (mean age 54.8±3.1 years) with ST elevation acute coronary syndrome resulting in Q-wave myocardial infarction of the left ventricle. From the first hours complex therapy of these patients comprised meldonium (1 g/day intravenously for 2 weeks then orally until 1.5 months).
V P, Mikhin, M A, Cherniatina, G V, Panchenko, A V, Kharchenko, Iu A, Tsukanova   +4 more
openaire   +2 more sources